Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Deoxycytidine"" wg kryterium: Temat


Tytuł:
Identification and Clinical Significance of Pancreatic Cancer Stem Cells and Their Chemotherapeutic Drug Resistance.
Autorzy:
Kuo YC; Department of Surgery, Chang Gung Memorial Hospital, Chang Gung University, Lin-Kou, Taoyuan 333, Taiwan.
Kou HW; Department of Surgery, Chang Gung Memorial Hospital, Chang Gung University, Lin-Kou, Taoyuan 333, Taiwan.
Hsu CP; Department of Surgery, Chang Gung Memorial Hospital, Chang Gung University, Lin-Kou, Taoyuan 333, Taiwan.
Lo CH; Department of Surgery, Chang Gung Memorial Hospital, Chang Gung University, Lin-Kou, Taoyuan 333, Taiwan.
Hwang TL; Department of Surgery, Chang Gung Memorial Hospital, Chang Gung University, Lin-Kou, Taoyuan 333, Taiwan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Apr 15; Vol. 24 (8). Date of Electronic Publication: 2023 Apr 15.
Typ publikacji:
Journal Article
MeSH Terms:
Deoxycytidine*/pharmacology
Deoxycytidine*/therapeutic use
Pancreatic Neoplasms*/metabolism
Male ; Humans ; Epithelial Cell Adhesion Molecule/metabolism ; Clinical Relevance ; Gemcitabine ; Drug Resistance, Multiple ; Neoplastic Stem Cells/metabolism ; Cell Line, Tumor ; Drug Resistance, Neoplasm ; Epithelial-Mesenchymal Transition ; Pancreatic Neoplasms
Czasopismo naukowe
Tytuł:
EGR1 mediates MDR1 transcriptional activity regulating gemcitabine resistance in pancreatic cancer.
Autorzy:
Yang Z; Department of Gastroenterology, Guangxi Medical University Cancer Hospital, No 71 Hedi Road, Nanning, Guangxi Zhuang Autonomous Region, PR China.
Chen F; Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, No 6 Shuangyong Road, Nanning, Guangxi Zhuang Autonomous Region, PR China.
Wei D; Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, No 6 Shuangyong Road, Nanning, Guangxi Zhuang Autonomous Region, PR China.
Chen F; Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, No 6 Shuangyong Road, Nanning, Guangxi Zhuang Autonomous Region, PR China.
Jiang H; Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, No 6 Shuangyong Road, Nanning, Guangxi Zhuang Autonomous Region, PR China. .
Qin S; Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, No 6 Shuangyong Road, Nanning, Guangxi Zhuang Autonomous Region, PR China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Feb 26; Vol. 24 (1), pp. 268. Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:
Journal Article
MeSH Terms:
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/genetics
Pancreatic Neoplasms*/metabolism
Carcinoma, Pancreatic Ductal*/drug therapy
Carcinoma, Pancreatic Ductal*/genetics
Carcinoma, Pancreatic Ductal*/pathology
Animals ; Humans ; Gemcitabine ; Deoxycytidine/pharmacology ; Deoxycytidine/therapeutic use ; Drug Resistance, Neoplasm/genetics ; Cell Line, Tumor ; Apoptosis ; Early Growth Response Protein 1/genetics
Czasopismo naukowe
Tytuł:
Cannabigerol Induces Autophagic Cell Death by Inhibiting EGFR-RAS Pathways in Human Pancreatic Ductal Adenocarcinoma Cell Lines.
Autorzy:
Zeppa L; School of Pharmacy, University of Camerino, Via Madonna delle Carceri 9, 62032 Camerino, MC, Italy.; Integrative Therapy Discovery Lab, University of Camerino, 62032 Camerino, MC, Italy.
Aguzzi C; School of Pharmacy, University of Camerino, Via Madonna delle Carceri 9, 62032 Camerino, MC, Italy.; Integrative Therapy Discovery Lab, University of Camerino, 62032 Camerino, MC, Italy.
Morelli MB; School of Pharmacy, University of Camerino, Via Madonna delle Carceri 9, 62032 Camerino, MC, Italy.; Integrative Therapy Discovery Lab, University of Camerino, 62032 Camerino, MC, Italy.
Marinelli O; School of Pharmacy, University of Camerino, Via Madonna delle Carceri 9, 62032 Camerino, MC, Italy.; Integrative Therapy Discovery Lab, University of Camerino, 62032 Camerino, MC, Italy.
Giangrossi M; School of Pharmacy, University of Camerino, Via Madonna delle Carceri 9, 62032 Camerino, MC, Italy.
Luongo M; 'Maria Guarino' Foundation-AMOR No Profit Association, 80078 Pozzuoli, NA, Italy.
Amantini C; School of Bioscience and Veterinary Medicine, University of Camerino, 62032 Camerino, MC, Italy.
Santoni G; School of Pharmacy, University of Camerino, Via Madonna delle Carceri 9, 62032 Camerino, MC, Italy.
Nabissi M; School of Pharmacy, University of Camerino, Via Madonna delle Carceri 9, 62032 Camerino, MC, Italy.; Integrative Therapy Discovery Lab, University of Camerino, 62032 Camerino, MC, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 07; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:
Journal Article
MeSH Terms:
Autophagic Cell Death*/drug effects
Cannabinoids*/pharmacology
Carcinoma, Pancreatic Ductal*/drug therapy
Carcinoma, Pancreatic Ductal*/genetics
Carcinoma, Pancreatic Ductal*/metabolism
Pancreatic Neoplasms*/metabolism
Humans ; Apoptosis ; Cell Line, Tumor ; Deoxycytidine/pharmacology ; Deoxycytidine/therapeutic use ; ErbB Receptors/antagonists & inhibitors ; Proto-Oncogene Proteins p21(ras)/antagonists & inhibitors
Czasopismo naukowe
Tytuł:
ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells.
Autorzy:
Bergonzini C; Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands.
Gregori A; Physics of Life Processes, Leiden Institute of Physics, Leiden University, Leiden, The Netherlands.; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University, Amsterdam, The Netherlands.
Hagens TMS; Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands.
van der Noord VE; Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands.
van de Water B; Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands.
Zweemer AJM; Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands.
Coban B; Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands.
Capula M; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University, Amsterdam, The Netherlands.; Cancer Pharmacology Lab, Fondazione Pisana Per La Scienza, San Giuliano, Pisa, Italy.
Mantini G; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University, Amsterdam, The Netherlands.
Botto A; Proteomics and Metabolomics Lab, Fondazione Pisana Per La Scienza, San Giuliano, Pisa, Italy.; Department of Chemistry and Industrial Chemistry, University of Pisa, Pisa, Italy.
Finamore F; Proteomics and Metabolomics Lab, Fondazione Pisana Per La Scienza, San Giuliano, Pisa, Italy.
Garajova I; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
McDonnell LA; Proteomics and Metabolomics Lab, Fondazione Pisana Per La Scienza, San Giuliano, Pisa, Italy.
Schmidt T; Physics of Life Processes, Leiden Institute of Physics, Leiden University, Leiden, The Netherlands.
Giovannetti E; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University, Amsterdam, The Netherlands. .; Cancer Pharmacology Lab, Fondazione Pisana Per La Scienza, San Giuliano, Pisa, Italy. .
Danen EHJ; Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Jan 02; Vol. 43 (1), pp. 4. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article
MeSH Terms:
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/genetics
Pancreatic Neoplasms*/metabolism
Carcinoma, Pancreatic Ductal*/drug therapy
Carcinoma, Pancreatic Ductal*/genetics
Carcinoma, Pancreatic Ductal*/pathology
Humans ; Paclitaxel/pharmacology ; Paclitaxel/therapeutic use ; Gemcitabine ; Deoxycytidine/pharmacology ; Deoxycytidine/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; ATP Binding Cassette Transporter, Subfamily B/genetics
Czasopismo naukowe
Tytuł:
[Gemcitabine long-term maintenance chemotherapy benefits patients with survival: a multicenter, real-world study of advanced breast cancer treatment in China].
Autorzy:
Yue J; Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Song GH; Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Li HP; Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Sun T; Department of Breast Medicine, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang 110042, China.
Song LH; Department of Medical Oncology, Cancer Research Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China.
Tong ZS; Department of Breast Oncology, Tianjin Medical University Cancer Hospital, National Clinical Research Center of Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
Zhang LL; Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.
Song ZC; Breast Cancer, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
Ouyang QC; Department of Breast Cancer Medical Oncology, Hunan Cancer Hospital, Changsha 410006, China.
Yang J; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710049, China.
Pan YY; Department of Medical Oncology, Provincial Hospital Affiliated to Anhui Medical University, Hefei 230001, China.
Yuan P; Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2024 Mar 23; Vol. 46 (3), pp. 249-255.
Typ publikacji:
Multicenter Study; English Abstract; Journal Article
MeSH Terms:
Gemcitabine*
Breast Neoplasms*/pathology
Humans ; Middle Aged ; Female ; Deoxycytidine/therapeutic use ; Maintenance Chemotherapy ; Treatment Outcome ; Antineoplastic Combined Chemotherapy Protocols/adverse effects
Czasopismo naukowe
Tytuł:
Comparison of neoadjuvant treatment and surgery first for resectable or borderline resectable pancreatic carcinoma: A systematic review and network meta-analysis of randomized controlled trials.
Autorzy:
Huan L; Department of Hepatopancreatobiliary Surgery, Chongqing Fifth People's Hospital, Chongqing, Chongqing, China.
Yu F; Department of Hepatopancreatobiliary Surgery, Chongqing Fifth People's Hospital, Chongqing, Chongqing, China.
Cao D; Department of Hepatopancreatobiliary Surgery, Chongqing Fifth People's Hospital, Chongqing, Chongqing, China.
Zhou H; Department of Hepatopancreatobiliary Surgery, Chongqing Fifth People's Hospital, Chongqing, Chongqing, China.
Qin M; Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, China.
Cao Y; Department of Hepatopancreatobiliary Surgery, Chongqing Fifth People's Hospital, Chongqing, Chongqing, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 07; Vol. 19 (3), pp. e0295983. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024).
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Neoadjuvant Therapy*/methods
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/surgery
Humans ; Gemcitabine ; Capecitabine/therapeutic use ; Cisplatin/therapeutic use ; Epirubicin/therapeutic use ; Network Meta-Analysis ; Bayes Theorem ; Randomized Controlled Trials as Topic ; Deoxycytidine/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols
Czasopismo naukowe
Tytuł:
Pancreatic adenocarcinoma third line systemic treatments: a retrospective cohort study.
Autorzy:
Gueiderikh A; Département de médecine oncologique, Gustave Roussy, 94800, Villejuif, France.; Université Paris Saclay, 91471, Orsay, France.
Tarabay A; Département de médecine oncologique, Gustave Roussy, 94800, Villejuif, France.
Abdelouahab M; Département de statistiques, Gustave Roussy, 94800, Villejuif, France.
Smolenschi C; Département de médecine oncologique, Gustave Roussy, 94800, Villejuif, France.; Gustave Roussy, DITEP, 94800, Villejuif, France.
Tanguy ML; Département de statistiques, Gustave Roussy, 94800, Villejuif, France.
Valery M; Département de médecine oncologique, Gustave Roussy, 94800, Villejuif, France.
Malka D; Département d'oncologie médicale, Institut Mutualiste Montsouris, 75014, Paris, France.
Pudlarz T; Département de médecine oncologique, Gustave Roussy, 94800, Villejuif, France.
Fuerea A; Département de médecine oncologique, Gustave Roussy, 94800, Villejuif, France.
Boige V; Département de médecine oncologique, Gustave Roussy, 94800, Villejuif, France.
Hollebecque A; Département de médecine oncologique, Gustave Roussy, 94800, Villejuif, France.; Gustave Roussy, DITEP, 94800, Villejuif, France.
Ducreux M; Département de médecine oncologique, Gustave Roussy, 94800, Villejuif, France.; Université Paris Saclay, 91471, Orsay, France.
Boilève A; Département de médecine oncologique, Gustave Roussy, 94800, Villejuif, France. .; Université Paris Saclay, 91471, Orsay, France. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Feb 26; Vol. 24 (1), pp. 272. Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:
Journal Article
MeSH Terms:
Pancreatic Neoplasms*/pathology
Adenocarcinoma*/pathology
Humans ; Gemcitabine ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Retrospective Studies ; Erlotinib Hydrochloride/therapeutic use ; Deoxycytidine ; Fluorouracil ; Leucovorin/therapeutic use ; Paclitaxel ; Albumins
Czasopismo naukowe
Tytuł:
First-in-Class Humanized Antibody against Alternatively Spliced Tissue Factor Augments Anti-Metastatic Efficacy of Chemotherapy in a Preclinical Model of Pancreatic Ductal Adenocarcinoma.
Autorzy:
Lewis CS; Division of Hematology/Oncology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.
Backman C; Division of Hematology/Oncology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.
Ahsan S; Division of Hematology/Oncology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.
Cliff A; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Hariharan A; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Yeh JJ; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Departments of Surgery and Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Zhang X; Division of Environmental Genetics and Molecular Toxicology, Department of Environmental and Public Health Sciences, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.
Xie C; Division of Biostatistics and Bioinformatics, Department of Environmental and Public Health Sciences, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.
Sohal DPS; Division of Hematology/Oncology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.
Bogdanov VY; Division of Hematology/Oncology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 23; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Pancreatic Ductal*/pathology
Pancreatic Neoplasms*/pathology
Humans ; Thromboplastin ; Gemcitabine ; Antibodies, Monoclonal, Humanized/therapeutic use ; Leukocytosis/drug therapy ; Cell Line, Tumor ; Deoxycytidine/pharmacology ; Paclitaxel/therapeutic use
Czasopismo naukowe
Tytuł:
Effectiveness of azvudine in reducing mortality of COVID-19 patients: a systematic review and meta-analysis.
Autorzy:
Wang Y; Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, Dongcheng District, 100730, Beijing, China.
Xie H; Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, Dongcheng District, 100730, Beijing, China.
Wang L; Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, Dongcheng District, 100730, Beijing, China.
Fan J; Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, Dongcheng District, 100730, Beijing, China.
Zhang Y; International Medical Services, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Pan S; Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, Dongcheng District, 100730, Beijing, China.
Zhou W; Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, Dongcheng District, 100730, Beijing, China.
Chen Q; Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, Dongcheng District, 100730, Beijing, China.
Liu X; Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, Dongcheng District, 100730, Beijing, China.
Wu A; Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, Dongcheng District, 100730, Beijing, China.
Zhang H; Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, Dongcheng District, 100730, Beijing, China.
Wang J; Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, Dongcheng District, 100730, Beijing, China.
Tian X; Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, Dongcheng District, 100730, Beijing, China. .
Pokaż więcej
Źródło:
Virology journal [Virol J] 2024 Feb 23; Vol. 21 (1), pp. 46. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
COVID-19*
Azides*
Deoxycytidine/*analogs & derivatives
Humans ; Cohort Studies ; China ; Databases, Factual
Czasopismo naukowe
Tytuł:
The efficacy and safety of tislelizumab combined with gemcitabine plus cisplatin in the treatment of postoperative patients with muscle-invasive upper tract urothelial carcinoma.
Autorzy:
Zhang J; Department of Urology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Yang M; Department of Urology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Wei D; Department of Urology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Zhang D; Department of Urology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Chen Z; Department of Urology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China. .
Zhu H; Department of Urology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Feb 13; Vol. 24 (1), pp. 202. Date of Electronic Publication: 2024 Feb 13.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Transitional Cell*/drug therapy
Carcinoma, Transitional Cell*/surgery
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/surgery
Antibodies, Monoclonal, Humanized*
Humans ; Cisplatin/therapeutic use ; Gemcitabine ; Retrospective Studies ; Deoxycytidine/adverse effects ; Muscles ; Antineoplastic Combined Chemotherapy Protocols/adverse effects
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies